This scoping review highlighted emerging but heterogeneous use of CGM metrics in CGM-integrated pharmacists' services in diabetes care. While reported outcomes were consistently positive, most studies focused on clinical parameters, particularly A1C. Future research should place greater emphasis on evaluating humanistic and economic outcomes of CGM on pharmacist-involved diabetes services.
Lee et al. (Tue,) studied this question.